136 related articles for article (PubMed ID: 9459455)
1. From the Food and Drug Administration.
Nightingale SL
JAMA; 1998 Feb; 279(5):346. PubMed ID: 9459455
[No Abstract] [Full Text] [Related]
2. Mibefradil--a new calcium-channel blocker.
Med Lett Drugs Ther; 1997 Nov; 39(1013):103-5. PubMed ID: 9391500
[No Abstract] [Full Text] [Related]
3. Reports prompt new warnings on LMW heparins, heparinoids.
Am J Health Syst Pharm; 1998 Feb; 55(3):210. PubMed ID: 9492250
[No Abstract] [Full Text] [Related]
4. What lessons can be learnt from withdrawal of mibefradil from the market?
Po AL; Zhang WY
Lancet; 1998 Jun; 351(9119):1829-30. PubMed ID: 9652662
[No Abstract] [Full Text] [Related]
5. Mibefradil and an effective formulary system.
Vermeulen LC; Dunham DB
Am J Health Syst Pharm; 1998 Sep; 55(18):1934-5. PubMed ID: 9784776
[No Abstract] [Full Text] [Related]
6. Spinal subarachnoid hematoma after lumbar puncture and heparinization: a case report, review of the literature, and discussion of anesthetic implications.
Owens EL; Kasten GW; Hessel EA
Anesth Analg; 1986 Nov; 65(11):1201-7. PubMed ID: 3767019
[No Abstract] [Full Text] [Related]
7. The withdrawal of mibefradil (Posicor).
Griffin JP
Adverse Drug React Toxicol Rev; 1998; 17(2-3):59-60. PubMed ID: 9838964
[No Abstract] [Full Text] [Related]
8. Comment: mibefradil, a new class of calcium-channel antagonists.
Otterman S
Ann Pharmacother; 1998 Dec; 32(12):1372. PubMed ID: 9876826
[No Abstract] [Full Text] [Related]
9. Rhabdomyolysis due to interaction of simvastatin with mibefradil.
Schmassmann-Suhijar D; Bullingham R; Gasser R; Schmutz J; Haefeli WE
Lancet; 1998 Jun; 351(9120):1929-30. PubMed ID: 9654265
[No Abstract] [Full Text] [Related]
10. Mibefradil withdrawn from the market.
Billups SJ; Carter BL
Ann Pharmacother; 1998; 32(7-8):841. PubMed ID: 9681103
[No Abstract] [Full Text] [Related]
11. Roche, FDA announce new drug-interaction warnings for mibefradil.
Am J Health Syst Pharm; 1998 Feb; 55(3):210. PubMed ID: 9492249
[No Abstract] [Full Text] [Related]
12. Hazards of subdural and epidural anesthesia during anticoagulant therapy: a case report and review.
DeAngelis J
Anesth Analg; 1972; 51(5):676-9. PubMed ID: 4672158
[No Abstract] [Full Text] [Related]
13. When you suspect epidural hematoma.
Stillwell SB
Am J Nurs; 2000 Sep; 100(9):68-70, 72, 74 passim. PubMed ID: 11002797
[No Abstract] [Full Text] [Related]
14. Editorial on LMWH and regional anaesthesia--dangerous recommendations.
Ljungström KG
Acta Anaesthesiol Scand; 1999 Jan; 43(1):116-8. PubMed ID: 9926204
[No Abstract] [Full Text] [Related]
15. Subacute spinal subarachnoid hematoma following combined spinal-epidural anesthesia treated conservatively: a case report.
Luo F; Cai XJ; Li ZY
J Clin Anesth; 2012 Sep; 24(6):519-20. PubMed ID: 22986330
[No Abstract] [Full Text] [Related]
16. [Induction of bradycardia by mibefradil in antihypertensive combination therapy].
Wagner J; Ritz E
Dtsch Med Wochenschr; 1998 Apr; 123(17):547. PubMed ID: 9601479
[No Abstract] [Full Text] [Related]
17. FDA public health advisory: low molecular-weight heparin and spinal/epidural anesthesia or spinal puncture.
Lumpkin MM
Int J Trauma Nurs; 1998; 4(2):56-7. PubMed ID: 9855967
[No Abstract] [Full Text] [Related]
18. Mibefradil (posicor).
Giles TD
Compr Ther; 1997 Nov; 23(11):761-3. PubMed ID: 9360806
[No Abstract] [Full Text] [Related]
19. Mibefradil (Posicor) induced sinus arrest.
Sanders P; Walker J; Craig RJ; Hii JT; Steele PM
Aust N Z J Med; 1998 Dec; 28(6):836-7. PubMed ID: 9972419
[No Abstract] [Full Text] [Related]
20. Spinal/epidural haematomas associated with neuraxial anaesthesia in the presence of heparin and low-molecular-weight heparins.
Payne K; Mehta U
S Afr Med J; 2000 Jun; 90(6):604. PubMed ID: 10918889
[No Abstract] [Full Text] [Related]
[Next] [New Search]
